COVID‐19 post hematopoietic cell transplant, a report of 11 cases from a single center.
In late 2019 the coronavirus disease‐2019 (COVID‐19) pandemic caused by SARS Coronavirus 2 (SARS‐CoV‐2) started in Wuhan, China. Cancer patients are immunosuppressed from their disease and the therapy they receive.Hematopoietic cell transplant (HCT) recipients are a subgroup of patients that are sev...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2020-08-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | https://www.mjhid.org/index.php/mjhid/article/view/4336 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846147048339931136 |
|---|---|
| author | Afadil Adam |
| author_facet | Afadil Adam |
| author_sort | Afadil Adam |
| collection | DOAJ |
| description | In late 2019 the coronavirus disease‐2019 (COVID‐19) pandemic caused by SARS Coronavirus 2 (SARS‐CoV‐2) started in Wuhan, China. Cancer patients are immunosuppressed from their disease and the therapy they receive.Hematopoietic cell transplant (HCT) recipients are a subgroup of patients that are severely immunocompromised and may be at an even higher risk of a complicated course during this infection.We herein report the outcomes and course of 11 sequential cases of HCT recipients infected by SARS‐CoV‐2 treated in our center.The patients age ranged from 17 to 60 years, the duration from transplant to infection ranged from day +5 to 192 months, 6 patients were post allo-HCT, 4 post auto-HCT and one had both allo and auto-HCT. The presenting symptoms were not different from other viral illnesses. The majority had mild COVID-19 stage, while 3 had moderate stage on presentation. None of the patients required oxygen supplementation nor mechanical ventilation. |
| format | Article |
| id | doaj-art-a1e317eae9a74244b3cc0d32eb4ae27e |
| institution | Kabale University |
| issn | 2035-3006 |
| language | English |
| publishDate | 2020-08-01 |
| publisher | PAGEPress Publications |
| record_format | Article |
| series | Mediterranean Journal of Hematology and Infectious Diseases |
| spelling | doaj-art-a1e317eae9a74244b3cc0d32eb4ae27e2024-12-02T00:04:33ZengPAGEPress PublicationsMediterranean Journal of Hematology and Infectious Diseases2035-30062020-08-0112110.4084/mjhid.2020.070COVID‐19 post hematopoietic cell transplant, a report of 11 cases from a single center.Afadil Adam0{'en_US': 'King Faisal Specialist Hospital'}In late 2019 the coronavirus disease‐2019 (COVID‐19) pandemic caused by SARS Coronavirus 2 (SARS‐CoV‐2) started in Wuhan, China. Cancer patients are immunosuppressed from their disease and the therapy they receive.Hematopoietic cell transplant (HCT) recipients are a subgroup of patients that are severely immunocompromised and may be at an even higher risk of a complicated course during this infection.We herein report the outcomes and course of 11 sequential cases of HCT recipients infected by SARS‐CoV‐2 treated in our center.The patients age ranged from 17 to 60 years, the duration from transplant to infection ranged from day +5 to 192 months, 6 patients were post allo-HCT, 4 post auto-HCT and one had both allo and auto-HCT. The presenting symptoms were not different from other viral illnesses. The majority had mild COVID-19 stage, while 3 had moderate stage on presentation. None of the patients required oxygen supplementation nor mechanical ventilation.https://www.mjhid.org/index.php/mjhid/article/view/4336Coronavirus, COVID-19, SARS-CoV-2, hematopoietic cell transplant, bone, marrow transplant, stem cell transplant, multiple myeloma, acute lymphoblastic leukemia, lymphoma |
| spellingShingle | Afadil Adam COVID‐19 post hematopoietic cell transplant, a report of 11 cases from a single center. Mediterranean Journal of Hematology and Infectious Diseases Coronavirus, COVID-19, SARS-CoV-2, hematopoietic cell transplant, bone, marrow transplant, stem cell transplant, multiple myeloma, acute lymphoblastic leukemia, lymphoma |
| title | COVID‐19 post hematopoietic cell transplant, a report of 11 cases from a single center. |
| title_full | COVID‐19 post hematopoietic cell transplant, a report of 11 cases from a single center. |
| title_fullStr | COVID‐19 post hematopoietic cell transplant, a report of 11 cases from a single center. |
| title_full_unstemmed | COVID‐19 post hematopoietic cell transplant, a report of 11 cases from a single center. |
| title_short | COVID‐19 post hematopoietic cell transplant, a report of 11 cases from a single center. |
| title_sort | covid 19 post hematopoietic cell transplant a report of 11 cases from a single center |
| topic | Coronavirus, COVID-19, SARS-CoV-2, hematopoietic cell transplant, bone, marrow transplant, stem cell transplant, multiple myeloma, acute lymphoblastic leukemia, lymphoma |
| url | https://www.mjhid.org/index.php/mjhid/article/view/4336 |
| work_keys_str_mv | AT afadiladam covid19posthematopoieticcelltransplantareportof11casesfromasinglecenter |